Minocycline chemical structure
Find information on thousands of medical conditions and prescription drugs.

Arestin


Minocycline hydrochloride, also known as minocycline, is a member of the broad spectrum tetracycline antibiotics, and has a broader spectrum than the other members. As a result of its long half-life it generally has serum levels 2-4 times that of most other tetracyclines (150 mg giving 16 times the activity levels compared to 250 mg of tetracycline at 24-48 hours). more...

Home
Diseases
Medicines
A
8-Hour Bayer
Abacavir
Abamectin
Abarelix
Abciximab
Abelcet
Abilify
Abreva
Acamprosate
Acarbose
Accolate
Accoleit
Accupril
Accurbron
Accure
Accuretic
Accutane
Acebutolol
Aceclidine
Acepromazine
Acesulfame
Acetaminophen
Acetazolamide
Acetohexamide
Acetohexamide
Acetylcholine chloride
Acetylcysteine
Acetyldigitoxin
Aciclovir
Acihexal
Acilac
Aciphex
Acitretin
Actifed
Actigall
Actiq
Actisite
Actonel
Actos
Acular
Acyclovir
Adalat
Adapalene
Adderall
Adefovir
Adrafinil
Adriamycin
Adriamycin
Advicor
Advil
Aerobid
Aerolate
Afrinol
Aggrenox
Agomelatine
Agrylin
Airomir
Alanine
Alavert
Albendazole
Alcaine
Alclometasone
Aldomet
Aldosterone
Alesse
Aleve
Alfenta
Alfentanil
Alfuzosin
Alimta
Alkeran
Alkeran
Allegra
Allopurinol
Alora
Alosetron
Alpidem
Alprazolam
Altace
Alteplase
Alvircept sudotox
Amantadine
Amaryl
Ambien
Ambisome
Amfetamine
Amicar
Amifostine
Amikacin
Amiloride
Amineptine
Aminocaproic acid
Aminoglutethimide
Aminophenazone
Aminophylline
Amiodarone
Amisulpride
Amitraz
Amitriptyline
Amlodipine
Amobarbital
Amohexal
Amoxapine
Amoxicillin
Amoxil
Amphetamine
Amphotec
Amphotericin B
Ampicillin
Anafranil
Anagrelide
Anakinra
Anaprox
Anastrozole
Ancef
Android
Anexsia
Aniracetam
Antabuse
Antitussive
Antivert
Apidra
Apresoline
Aquaphyllin
Aquaphyllin
Aranesp
Aranesp
Arava
Arestin
Arestin
Argatroban
Argatroban
Argatroban
Argatroban
Arginine
Arginine
Aricept
Aricept
Arimidex
Arimidex
Aripiprazole
Aripiprazole
Arixtra
Arixtra
Artane
Artane
Artemether
Artemether
Artemisinin
Artemisinin
Artesunate
Artesunate
Arthrotec
Arthrotec
Asacol
Ascorbic acid
Asmalix
Aspartame
Aspartic acid
Aspirin
Astemizole
Atacand
Atarax
Atehexal
Atenolol
Ativan
Atorvastatin
Atosiban
Atovaquone
Atridox
Atropine
Atrovent
Augmentin
Aureomycin
Avandia
Avapro
Avinza
Avizafone
Avobenzone
Avodart
Axid
Axotal
Azacitidine
Azahexal
Azathioprine
Azelaic acid
Azimilide
Azithromycin
Azlocillin
Azmacort
Aztreonam
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

It is marketed under several trade names, including Minomycin, Minocin, Arestin, and Dynacin.

Indications

It is primarily used to treat acne and rosacea as the once daily 100mg doasage is far easier for patients than the four times a day required with Tetracycline or Oxytetracycline.

Although minocycline's broader spectrum of activity, compared to other members of the group, includes activity against Neisseria meningitidis, its use as a prophylaxis is no longer recomended because of side effects (dizziness and vertigo).

Cautions and Side effects

In additon to those common to the Tetracycline antibiotics group, minocycline may be used in renal impairment, but may aggrevate systemic lupus erythematosus. ( and ).

Possible additional indications

Current research is examining the possible neuroprotective effects of minocycline against progression of Huntington's Disease, an inherited neurodegenerative disorder. (Research is summarized here and here.) The neuroprotective action of minocycline may include its inhibitory effect on 5-lipoxygenase , an inflammatory enzyme associated with brain aging .

Read more at Wikipedia.org


[List your site here Free!]


Update: 76% of Dental Professionals Surveyed by Health Products Research, Inc.(R) Say OraPharma Provides the Best Level of Customer Support
From Market Wire, 6/3/05

OraPharma, Inc., a pharmaceutical company specializing in products for the dental market, was rated as the top company for customer support by a survey of dental health professionals recently conducted by Health Products Research, Inc.® (HPR).

According to James Charnetski, Vice President of Market Research/Health Products Research, "The fact that over three-quarters of the dental offices surveyed cited OraPharma as providing the best level of support to their practice out of companies with an interest in the management of periodontal disease clearly places the organization as the best in its class. A score of 50% is considered a significant accomplishment -- the 76% level demonstrates OraPharma's commitment to providing unsurpassed service and support for its customers."

The extensive blinded research findings were the result of HPR's Metropolitan Area Promotional Audit (MPA). This self-reported diary was completed by 647 randomly selected offices from across the U.S. Offices were queried on their hygiene and periodontal disease treatment protocols as well as the products they use and the companies that support those products.

"We are very proud of the HPR survey result," said Michael Cavanaugh, Executive Director, Marketing. "Our commercial team received very high ratings from dental practitioners, especially pertaining to our account managers' professionalism and our innovative support of dental professionals and their patients."

About OraPharma, Inc.

OraPharma, Inc., is a specialty pharmaceutical company, which discovers, develops, and commercializes therapeutics for oral health. OraPharma is dedicated to the dental community, specifically the periodontal space with its lead product, ARESTIN® (minocycline hydrochloride) Microspheres, 1 mg.

In addition to ARESTIN®, OraPharma also distributes Oraqix® (lidocaine and prilocaine periodontal gel) 2.5% / 2.5%, a new sub-gingival local anesthetic periodontal gel, indicated for adults who require localized anesthesia in periodontal pockets during scaling and/or root planing and is manufactured by Dentsply Pharmaceuticals.

Along with ARESTIN® and Oraqix®, OraPharma also promotes REACH® ACCESS(TM) Daily Flosser, REACH® CLEAN BURST(TM) Dental Floss and ACT® Anticavity Fluoride Rinse, distributed by McNeil-PPC, Inc., to the dental community.

About ARESTIN®

OraPharma's flagship product ARESTIN® is indicated as an adjunct to scaling and/or root planing procedures for reduction of pocket depth in patients with adult periodontitis. ARESTIN® may be used as part of a periodontal maintenance program which includes good oral hygiene and scaling and/or root planing.

ARESTIN® contains minocycline, a tetracycline derivative, and therefore should not be used in children and in pregnant or nursing women. The use of drugs of the tetracycline class during tooth development may cause permanent discoloration of the teeth.

The most common treatment-emergent adverse events were headache (9.0%), infection (7.6%), flu syndrome (5.0%), and pain (4.3%). These occurred at a similar rate to scaling and/or root planing and scaling and/or root planing + placebo.

About Oraqix®

Oraqix,® manufactured for OraPharma, Inc. by Dentsply Pharmaceuticals, is the first FDA-approved subgingival anesthetic indicated for use in adults requiring anesthesia for scaling and/or root planing procedures. The patient friendly, needle-free application avoids patients concerns about needles and injections. Oraqix® is a trademark of Dentsply Pharmaceuticals.

For more information, visit www.orapharma.com or call 1-866-273-7846.

Contact: Lanmark Group Michael Ventriello mventriello@lanmarkgroup.com www.lanmarkgroup.com

Return to Arestin
Home Contact Resources Exchange Links ebay